GSEP
PRAX icon

Golden State Equity Partners’s Praxis Precision Medicines PRAX Stock Holding History

Golden State Equity Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24
Closed -$7.73K – 1369
2026
Q1 		$7.73K Buy
+24
New +$7.42K ﹤0.01% 1371

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Golden State Equity Partners's PRAX Position: Q2 2026 in Review

Golden State Equity Partners sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 24 shares — an estimated $7.73K sold.

Golden State Equity Partners first reported a position in PRAX in Q1 2026 and held it in 1 quarter. The position peaked at $7.73K in Q1 2026. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Golden State Equity Partners reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 24 Praxis Precision Medicines shares in Q2 2026, an estimated $7.73K.
  • Golden State Equity Partners first reported a position in Praxis Precision Medicines in Q1 2026 and held it in 1 quarter.
  • Golden State Equity Partners's Praxis Precision Medicines position peaked at $7.73K in Q1 2026.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.